This inventor holds 2 USPTO granted patents. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1999-2000.
Company Filing History:
Years Active: 1999-2000
Title: William K Eliason: Innovator in Glucocerebrosidase Research
Introduction
William K Eliason is a notable inventor based in Reston, VA (US). He has made significant contributions to the field of biotechnology, particularly in the development of treatments for Gaucher's disease. With a total of 2 patents, Eliason's work has had a profound impact on medical science.
Latest Patents
Eliason's latest patents focus on the synthesis of unique glucocerebrosidase. The first patent discloses a method for producing glucocerebrosidase through recombinant methods, which is crucial for the treatment of Gaucher's disease. This patent includes a cDNA for encoding the specific protein and outlines the method of preparing the construct used to produce the protein. The second patent presents a pharmaceutical composition that comprises a therapeutic amount of glycosylated recombinantly-produced human glucocerebrosidase protein in a pharmaceutically acceptable carrier. This invention also details a method for treating Gaucher's disease by administering the therapeutic composition to affected subjects.
Career Highlights
Eliason works for the United States of America as Represented by the Department of Health. His role in this esteemed organization underscores his commitment to advancing healthcare through innovative research and development.
Collaborations
Eliason has collaborated with notable colleagues, including Kara A Maysak and Brian M Martin. These partnerships have likely contributed to the success of his research and patent developments.
Conclusion
William K Eliason is a distinguished inventor whose work in glucocerebrosidase research has paved the way for new treatments for Gaucher's disease. His contributions to biotechnology continue to influence the medical field positively.